abstract |
Compounds for use in modulating a biological activity of a chemokine selected from MCP-1 and SDF-1, or for use in treating diseases and disorders associated with a biological activity of said chemokine, are provided herein. The compounds are collectively represented by Formulae Ia or Ib:wherein A, B D, E, G and R<sub>1</sub>-R<sub>5</sub> are as defined in the specification. |